PB

Priyadarshani Behera

Active Director Director DIN 09277113
DIN 09277113 First appointment Aug 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Priyadarshani Behera

Data last updated:

Priyadarshani Behera is a Director at Ramakanta Institute Of Medical Sciences Private Limited (since 2021). The company operates in Healthcare.

DIN 09277113
Primary Designation Director
Industry Healthcare
First Appointment 11 Aug 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Aug 20212021Active

Board colleagues of Priyadarshani Behera

Directorship timeline

Open interactive timeline →
Ramakanta Institute Of Medical Sciences Private Limited
Premium access

Shareholding and investment profile for Priyadarshani Behera

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priyadarshani Behera

Priyadarshani Behera currently holds 1 directorship: Ramakanta Institute Of Medical Sciences Private Limited (Director, since 11 Aug 2021).

Priyadarshani Behera was first appointed on 11 Aug 2021 as Director at Ramakanta Institute Of Medical Sciences Private Limited.

The current boards of Priyadarshani Behera's companies include Anjana Das (Ramakanta Institute Of Medical Sciences Private Limited), Ramakanta Mallick (Ramakanta Institute Of Medical Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available